5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Positive revenue growth while Consumer Cyclical median is negative. Peter Lynch might see a relative strength advantage in a tough sector.
12.82%
Positive gross profit growth while Consumer Cyclical median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
27.13%
EBIT growth exceeding 1.5x Consumer Cyclical median of 7.03%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
27.13%
Operating income growth exceeding 1.5x Consumer Cyclical median of 1.29%. Joel Greenblatt would see if unique processes drive exceptional profitability.
27.59%
Net income growth exceeding 1.5x Consumer Cyclical median of 9.79%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
121.43%
EPS growth exceeding 1.5x Consumer Cyclical median of 8.04%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
121.43%
Diluted EPS growth exceeding 1.5x Consumer Cyclical median of 7.86%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
0.96%
Share growth above Consumer Cyclical median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.96%
Diluted share change of 0.96% while Consumer Cyclical median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Negative OCF growth while Consumer Cyclical median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-142.71%
Negative FCF growth while Consumer Cyclical median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-29.04%
Negative 10Y revenue/share CAGR while Consumer Cyclical median is 20.42%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
8.85%
5Y revenue/share growth 1.25-1.5x Consumer Cyclical median of 7.83%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
1.36%
3Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 0.61%. Joel Greenblatt might see a short-term competitive advantage at play.
-52.74%
Negative 10Y OCF/share CAGR while Consumer Cyclical median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
172.35%
OCF/share CAGR of 172.35% while Consumer Cyclical median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
-43.77%
Negative 3Y OCF/share CAGR while Consumer Cyclical median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
121.16%
Net income/share CAGR exceeding 1.5x Consumer Cyclical median of 37.50% over a decade. Joel Greenblatt might see a standout compounder of earnings.
152.75%
5Y net income/share CAGR > 1.5x Consumer Cyclical median of 27.10%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
17.95%
3Y net income/share CAGR > 1.5x Consumer Cyclical median of 11.75%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
40.04%
Equity/share CAGR 1.25-1.5x Consumer Cyclical median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
41.47%
5Y equity/share CAGR > 1.5x Consumer Cyclical median of 17.00%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
28.79%
3Y equity/share CAGR > 1.5x Consumer Cyclical median of 6.55%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
AR growth of 25.14% while Consumer Cyclical median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
10.18%
Inventory growth far above Consumer Cyclical median. Jim Chanos suspects major issues in demand forecasting or potential obsolescence risk.
13.64%
Asset growth exceeding 1.5x Consumer Cyclical median of 0.41%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
12.97%
BV/share growth exceeding 1.5x Consumer Cyclical median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
2.86%
Slightly rising debt while Consumer Cyclical median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
-100.00%
R&D dropping while Consumer Cyclical median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
-49.54%
SG&A decline while Consumer Cyclical grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.